Bridging the Sim2Real Gap in Materials
Dunia Innovations Merges AI and Robotics to Accelerate Real-World Materials Discovery

Dunia Innovations is redefining how the world discovers new materials. By closing the “simulation-to-reality” gap, Dunia’s AI-driven autonomous lab, IRIS, fuses robotics, real-world data, and multi-modal learning to accelerate the design of next-generation materials. From energy to chemicals to advanced manufacturing, Dunia is building the discovery engine for a sustainable, abundant future.
CHEManager: Dunia’s tagline is “Bridging the Sim2Real gap in materials discovery.” What does that mean in practice?
Alex Hammer: For decades, materials science has been stuck in slow motion. We now start to have incredible simulations, but very little data to validate them. AI models can simulate thousands of interesting materials candidates, but frankly the only thing that matters is how those materials perform in the real world, at scale, and in actual industrial conditions. Dunia’s platform, IRIS, integrates AI with robotics to simulate, manufacture, stress-test, and analyze materials, learning from physical experiments and then continuously improving predictions and accelerating discovery.
Why is now the right time for this approach?
A. Hammer: The world has never been hungrier for breakthroughs. I mean in areas like clean energy, in sustainable chemicals, advanced manufacturing, etc. But the materials that enable these breakthroughs take decades to develop, and we just can’t afford to wait that long. AI has already transformed fields like protein design; we’re doing the same for materials but grounded in industrial data and automation.
What makes Dunia’s platform different from other AI-for-science efforts?
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
most read

Pharma 4.0—the Key Enabler for Successful Digital Transformation in Pharma
Part 3: Seven Theses for successful Digitalization in Pharma

US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.

ISPE Good Practice Guide: Validation 4.0
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.

Q1 2025 Chemical Industry: Diverging Trends
The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance
The ECA Foundation, one of the most important not-for-profit organizations for regulatory expertise in the pharmaceutical industry, aims to become the largest independent GMP/GDP organization in the world.











